top of page

Allara lands $26M to expand women’s hormone telehealth

That’s why more than four years ago, Blank left her job as a director of strategy at Ro, an online clinic that offers treatment for erectile dysfunction and menopause, to start Allara, a telehealth platform for women who suffer from hormone conditions like PCOS, endometriosis, and hypothyroidism. At Allara, patients receive in one place the type of care that Blank had to piecemeal together when she was first diagnosed with PCOS.


And it seems that the startup’s approach is working, especially for treating young women — the company’s average patient’s age is 30, Blank says. In 2024, Allara grew its revenue by four-times, and has just raised $26 million in Series B funding led by Index Ventures, with participation of GV just 14 months after raising a $10 million Series A.



Contact

New York

853 Broadway   |   Suite 1401

New York, NY 10003

Vanterra Ventures New York Office image

Miami

237 South Dixie Highway   |   4th Floor

Coral Gables, FL 33133

(212) 231-3930

  • LinkedIn
Vanterra Ventures Miami office image

©2025 Vanterra Ventures | Privacy Policy | Terms of Use | Accessibility Statement

We use cookies on our website to see how you interact with it. By using this site you agree to our use of such cookies.

The investments highlighted above are for informational purposes only and are not meant to be an exhaustive list of all investments made by Vanterra, its affiliates, and its principals.

bottom of page